March 5 (Reuters) - Bayer on Tuesday said it

won a trial in a lawsuit brought by a retired postal service

worker in Pennsylvania who alleged he developed non-Hodgkins

lymphoma from using the company's Roundup weedkiller.

In addition to the jury verdict in the Philadelphia Court of

Common Pleas, Bayer said a California farmer, who said he

contracted the same type of cancer from exposure to the product,

and his wife on Tuesday voluntarily dropped their lawsuit while

a trial was underway in the in state court in Sonoma County,

California.

"We continue to stand behind the safety of Roundup and will

confidently defend the safety of our products and our good faith

actions in any future litigation," Bayer said in a statement.

Scott Love, a lawyer for Carl Kline, the plaintiff in the

Pennsylvania case, said the jury had not been allowed to hear

key evidence, including a finding by a World Health Organization

body that glyphosate, Roundup's active ingredient, was likely

capable of causing cancer.

A lawyer for the California plaintiffs, Michael and Bobbie

Meyer, did not immediately respond to requests for comment. It

was not immediately clear why the Meyers dropped their case.

Tuesday's victories come on the heels of another trial win

for the company in Arkansas on Friday. Bayer has now prevailed

in 13 of the last 20 Roundup trials, while plaintiffs have

scored large verdicts totaling more than $4 billion, including

$2.25 billion in a single case in January.

The company is appealing its trial losses, which include

large punitive damages awards that are likely to be reduced

because they exceed U.S. Supreme Court guidance.

Around 165,000 claims have been brought in the U.S. against

Bayer over Roundup, which the company acquired as part of its

$63 billion purchase of U.S. agrochemical company Monsanto in

2018. Many were resolved as part of a $9.6 billion settlement in

2020, but about 54,000 remain.

Bayer CEO Bill Anderson told investors in a call on Tuesday

that he was "considering every possible means to bring closure"

to the litigation, including solutions "outside the courtroom,"

though he did not offer details.

The company phased out sales of glyphosate products for home

use last year, though it still sells other formulations under

the Roundup name.